Results 31 to 40 of about 518,303 (373)
British Journal of Dermatology, 2020 Tralokinumab is a fully human monoclonal antibody that specifically neutralizes interleukin‐13, a key driver of atopic dermatitis (AD).
J. Silverberg +11 more
semanticscholar +1 more source
Lime-induced phytophotodermatitis [PDF]
Journal of Community Hospital Internal Medicine Perspectives, 2014 This case describes a scenario of lime-induced phytophotodermatitis. Phytophotodermatitis is a dermatitis caused after the skin is exposed to photosensitizing compounds in plants and then exposed to sunlight.
Andrew Hankinson +2 more
doaj +1 more source
Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus.
New England Journal of Medicine, 2020 BACKGROUND Nemolizumab is a subcutaneously administered humanized monoclonal antibody against interleukin-31 receptor A, which is involved in pruritus and inflammation in atopic dermatitis.
K. Kabashima +3 more
semanticscholar +1 more source
In Memoriam: Dr.a Olívia Bordalo (1951 – 2011)
Revista da Sociedade Portuguesa de Dermatologia e Venereologia, 2011 .
An Goossens
doaj +1 more source
Pathophysiology of atopic dermatitis: Clinical implications.
Allergy and Asthma Proceedings, 2019 Atopic dermatitis (AD) is the most common chronic inflammatory skin disease. Genetic predisposition, epidermal barrier disruption, and dysregulation of the immune system are some of the critical components of AD.
Jihyun Kim, B. Kim, D. Leung
semanticscholar +1 more source
A Hybrid Deep Learning Approach for Diagnosis of the Erythemato-Squamous Disease [PDF]
2020 IEEE International Conference on Electronics, Computing and
Communication Technologies (CONECCT), 2019 The diagnosis of the Erythemato-squamous disease (ESD) is accepted as a difficult problem in dermatology. ESD is a form of skin disease. It generally causes redness of the skin and also may cause loss of skin. They are generally due to genetic or environmental factors.
arxiv +1 more source
Nomenclature and clinical phenotypes of atopic dermatitis
Therapeutic Advances in Chronic Disease, 2021 Atopic dermatitis is a heterogeneous disease and resists classification. In this review, we discuss atopic dermatitis nomenclature and identify morphologic phenotypes, which will facilitate correct diagnoses and development of treatment strategies.
G. Girolomoni +7 more
semanticscholar +1 more source
Epidemiology of atopic dermatitis in adults: Results from an international survey
Allergy. European Journal of Allergy and Clinical Immunology, 2018 There are gaps in our knowledge of the prevalence of adult atopic dermatitis (AD).
S. Barbarot +8 more
semanticscholar +1 more source
IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis. [PDF]
, 2020 Dupilumab is a fully human antibody to interleukin-4 receptor α that improves the signs and symptoms of moderate to severe atopic dermatitis (AD). To determine the effects of dupilumab on Staphylococcus aureus colonization and microbial diversity on the ...
Ardeleanu, Marius +16 more
core +2 more sources
Methylisothiazolinone and Methylchloroisothiazolinone New Insights [PDF]
European Medical Journal Dermatology, 2013 Methylisothiazolinone (MI), along with Kathon™ CG (methylchloroisothiazolinone/MI), are widely used preservatives to prevent bacterial overgrowth in aqueous solutions of various types of cosmetic, household, and industrial products. Because of its high
Ana Rita Rodrigues-Barata +1 more
doaj